Atrial fibrillation
Conditions
Interventions
RFA group and CBA group:ablation treatment
CB-1 group and CB-2 group:CB-1 and CB-2 ablation treatment
Sponsors
The First Affiliated Hospital of Xi’an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) diagnosis of atrial fibrillation: atrial fibrillation attacked at least 3 times in nearly 3 months, and at least 1 times confirmed by electrocardiogram; (2) at least one kind of antiarrhythmic drugs was ineffective or patients could not tolerate the AAD(including beta blockers); (3) aged 18-80 years old.
Exclusion criteria
Exclusion criteria: (1) left atrial diameter (LAD)> 50mm or left atrial thrombosis; (2) left ventricular ejection fraction (EF) < 40% or cardiac function III - IV level; (3) hypertrophic cardiomyopathy; (4) unstable angina pectoris or recent myocardial infarction; (5) cerebral apoplexy occurred in the last 6 months; (6) uncontrolled hyperthyroidism; (7) pregnancy; (8) thrombocythemia and thrombocytopenia; (9) high risk of bleeding or anticoagulant taboo; (10) the expected survival was less than 1 years; (11) unwilling to insist on treatment or unwilling to sign the informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy and safety of AF in RFA vs. CBA;The efficacy and safety of AF in CB-1 group vs. CB-2 group; | — |
Countries
China
Contacts
Public ContactChaofeng Sun
Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi’an Jiaotong University
Outcome results
None listed